Paul Craddy Ph.D.
Paul Craddy Ph.D.Managing Director and Founder
Paul’s expertise in global and European pricing and market access has been gained from many years working in world leading companies and consultancies, such as Takeda and IMS health/Cambridge Pharma.

During his time in industry, Paul led teams at Takeda and Nycomed responsible for developing launch pricing and reimbursement strategies, optimising price of in-market products and providing input into R&D for pipeline products.

Paul is a visiting lecturer at Grenoble Business school and frequently presents on cutting edge pricing and market access topics at major conferences.

Graham Foxon Ph.D. MBA
Graham Foxon Ph.D. MBAManaging Director and Founder
With over 14 years’ experience in both consultancy and pharmaceutical companies, Graham’s expertise is in developing global launch pricing strategies and producing HTA submissions to address payers’ requirements.

Graham’s industry experience includes GSK, start-up biotech and Ferring pharmaceuticals. During his time at Ferring, Graham was Global Head of Market Access and Pricing, taking responsibility for pharmaceutical & diagnostic products and product launches. Graham’s consultancy experience includes both IMS consulting (previously Cambridge Pharma) and Adelphi Values.

As a pricing and market access expert, Graham regularly speaks at conferences and is a guest lecturer at Grenoble Business school.

Our Team Members

Charlie Hewitt MSc
Charlie Hewitt MScAssociate Director
Charlie has over 6 years’ pharmaceutical consultancy experience, advising clients ranging from small biotech to large global pharma. Charlie possesses significant experience across a range of different project types, including in-depth market analysis, primary and secondary research, payer advisory boards, forecasting models, value propositions, commercial messaging development and literature reviews.

Prior to joining Remap Consulting, Charlie worked at Blueprint Partnership and InterPhase Consult, the strategy consulting arm of Ashfield Healthcare Communications.

Hannah Lorquet
Hannah LorquetConsultant
Hannah joins Remap Consulting with 12 years’ pharma experience split between both client and consultancy. Hannah started her career with AstraZeneca where she first gained experience of the drug development process before moving into a market access role within their UK marketing company.

Since making the switch to consultancy Hannah has held consultant roles with responsibility for delivering HTA submissions, real-world evidence, value demonstration and health economics projects. Hannah has experience across multiple therapy areas including rare diseases, asthma, diabetes and oncology. She has also carried out projects in biosimilars.

Hannah has a Master of Pharmacy degree from the University of Nottingham and completed her pre-registration training with University Hospitals of Leicester and AstraZeneca.

Sarah Bailey
Sarah BaileyTraining and Operations Manager
With over 16 years’ experience working within the pharmaceutical and healthcare consultancy industry, Sarah brings a wealth of experience in training development, project management and support. Using her design techniques, Sarah creates and delivers visually powerful, interactive market access eLearning training programs, ensuring content is created to a high standard that adheres to your company brand guidelines.

Prior to joining Remap Consulting, Sarah gained experience at Adelphi Values and AstraZeneca providing support for a variety of projects across various therapy areas.

Fatima Chunara BSc
Fatima Chunara BScSenior Analyst
Fatima is an experienced senior analyst who provides pharmaceutical clients with in-depth market access research and strategic insights. Her expertise includes pricing and reimbursement landscape summaries, strategic recommendation reports and developing global value dossiers

Fatima’s scientific background and business acumen has also enabled her to successfully complete disease opportunity assessments and develop strong value propositions for top pharmaceutical clients.

Prior to joining Remap Consulting, Fatima worked at McCann Health on a range of pricing and market access projects.

Michael Thomas BSc
Michael Thomas BScAnalyst
Mike is an analyst who is proficient in working with clients to understand and provide solutions to their market access problems.

Prior to joining Remap Consulting, Mike was a Medical Affairs Operations Executive at ViiV Healthcare. He has significant experience in project management, from projects involving clinical data tools to process improvement initiatives, as well as experience in the delivery of training of pricing and reimbursement systems across the world.

Mike has been involved on projects covering a diverse range of healthcare topics, including precision medicine, rare diseases and the treatment of HIV.

Mike has a BSc in Pharmacology from the University of Leeds.

Charlotte Wilson
Charlotte WilsonProject Administrator
Charlotte has over 18 years’ experience within the pharmaceutical industry across multiple roles. Within Remap Consulting, Charlotte supports projects from an administrative and logistical perspective, both internally and externally. Her expertise lies in market research, specifically secondary data analysis, which includes interpreting, reporting and presenting global brand performance data via a wide variety of commercial information sources and competitive intelligence.

Prior to joining Remap Consulting, Charlotte worked within Astrazeneca in international marketing functions across a range of therapy areas and brand teams.

Edward Rigby BSc
Edward Rigby BScAnalyst
Edward is an analyst capable of assessing and providing solutions to clients’ pricing and market access problems.
Prior to joining Remap Consulting, Edward was an intern consultant at IP Pragmatics, where he gained experience of market research and patent landscape analysis, while assisting in the commercialisation of new technologies within the biosciences. Edward has experience of working within a number of research areas, including genetics, medical devices and plant sciences.

Edward has a BSc in Genetics from the University of Liverpool.

Emily Sutton
Emily SuttonProject Administrator
Emily has over 15 years experience within the pharmaceutical industry with various project administrative roles in different stages of the life cycle process including Market Research, R&D, Marketing, Communications, Regulatory, HR & Finance. Educated to Postgraduate level and advanced Microsoft Office User Specialist Certification in Word, Excel and PowerPoint.

Powerpoint and Word are Emily’s specialist areas of expertise with an advanced in-depth knowledge of editing, formatting and design. Emily is a proactive & enthusiastic individual with natural creative flair and a ‘can do’ attitude. Prior to joining Remap Consulting, Emily worked at AstraZeneca and Adelphi International Research providing support for a variety of projects across various therapy areas.

Andreas
AndreasAssociate Consultant - Germany
Andreas has more than 20 years of industry experience in health care, having worked on Market Access and P&R in Germany, France, UK and Switzerland. Andreas gained his industry experience at Allergan, Lilly, BIOGEN and Medtronic. Andreas also worked as Director Outcomes Research at NHS Innovations, London and gave lectures on Market Access at the University of Lyon and Paris and the European Business School (EBS) in Oestrich-Winkel.

Andreas is regularly invited as an expert speaker on conferences around Market Access and as a member of advisory board panels to the pharmaceutical industry. He is the founder of the “European Journal of Health Economics”.

Andreas and Remap Consulting have collaborated on a wide range of pricing and market access projects, including payer advisory boards and payer scientific advice meetings.

Ben
BenAssociate Consultant - Emerging Markets
Ben has 14 years’ experience in market access for emerging markets, and has delivered more than 100 projects since 2010. His main areas of expertise include local market access dossier customisation, stakeholder research and landscaping, pricing studies and payer negotiation simulations.

Ben has worked extensively in Latin America, Asia-Pacific, Middle East & Africa and Eastern European countries, with a particular focus on the BRICMT markets and high-growth developing economies worldwide. He has worked in all major therapy areas, including oncology, diabetes, respiratory medicine and innovative vaccines.

Fluent in Spanish and Portuguese, Ben holds a Master’s degree from Oxford University.